291 related articles for article (PubMed ID: 34307295)
1. α-Synuclein: An All-Inclusive Trip Around its Structure, Influencing Factors and Applied Techniques.
Bisi N; Feni L; Peqini K; Pérez-Peña H; Ongeri S; Pieraccini S; Pellegrino S
Front Chem; 2021; 9():666585. PubMed ID: 34307295
[TBL] [Abstract][Full Text] [Related]
2. Novel Small Molecules Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein Protect Against Diverse α-Synuclein Mediated Dysfunctions.
Tóth G; Neumann T; Berthet A; Masliah E; Spencer B; Tao J; Jobling MF; Gardai SJ; Bertoncini CW; Cremades N; Bova M; Ballaron S; Chen XH; Mao W; Nguyen P; Tabios MC; Tambe MA; Rochet JC; Junker HD; Schwizer D; Sekul R; Ott I; Anderson JP; Szoke B; Hoffman W; Christodoulou J; Yednock T; Agard DA; Schenk D; McConlogue L
Sci Rep; 2019 Nov; 9(1):16947. PubMed ID: 31740740
[TBL] [Abstract][Full Text] [Related]
3. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
[TBL] [Abstract][Full Text] [Related]
4. Intracellular soluble α-synuclein oligomers reduce pyramidal cell excitability.
Kaufmann TJ; Harrison PM; Richardson MJ; Pinheiro TJ; Wall MJ
J Physiol; 2016 May; 594(10):2751-72. PubMed ID: 26915902
[TBL] [Abstract][Full Text] [Related]
5. Dynamical Behavior of Human α-Synuclein Studied by Quasielastic Neutron Scattering.
Fujiwara S; Araki K; Matsuo T; Yagi H; Yamada T; Shibata K; Mochizuki H
PLoS One; 2016; 11(4):e0151447. PubMed ID: 27097022
[TBL] [Abstract][Full Text] [Related]
6. The emerging role of α-synuclein truncation in aggregation and disease.
Sorrentino ZA; Giasson BI
J Biol Chem; 2020 Jul; 295(30):10224-10244. PubMed ID: 32424039
[TBL] [Abstract][Full Text] [Related]
7. Conformational equilibria in monomeric alpha-synuclein at the single-molecule level.
Sandal M; Valle F; Tessari I; Mammi S; Bergantino E; Musiani F; Brucale M; Bubacco L; Samorì B
PLoS Biol; 2008 Jan; 6(1):e6. PubMed ID: 18198943
[TBL] [Abstract][Full Text] [Related]
8. Lipids as
Ikenaka K; Suzuki M; Mochizuki H; Nagai Y
Front Neurosci; 2019; 13():693. PubMed ID: 31333408
[TBL] [Abstract][Full Text] [Related]
9. Dynamic Properties of Human α-Synuclein Related to Propensity to Amyloid Fibril Formation.
Fujiwara S; Kono F; Matsuo T; Sugimoto Y; Matsumoto T; Narita A; Shibata K
J Mol Biol; 2019 Aug; 431(17):3229-3245. PubMed ID: 31181290
[TBL] [Abstract][Full Text] [Related]
10. The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson's disease, multiple system atrophy and dementia with Lewy bodies.
Van der Perren A; Gelders G; Fenyi A; Bousset L; Brito F; Peelaerts W; Van den Haute C; Gentleman S; Melki R; Baekelandt V
Acta Neuropathol; 2020 Jun; 139(6):977-1000. PubMed ID: 32356200
[TBL] [Abstract][Full Text] [Related]
11. Similarity of the non-amyloid-β component and C-terminal tail of monomeric and tetrameric alpha-synuclein with 14-3-3 sigma.
Evans SR; West C; Klein-Seetharaman J
Comput Struct Biotechnol J; 2021; 19():5348-5359. PubMed ID: 34667532
[TBL] [Abstract][Full Text] [Related]
12. Oligomers of α-synuclein: picking the culprit in the line-up.
Lorenzen N; Otzen DE
Essays Biochem; 2014; 56():137-48. PubMed ID: 25131592
[TBL] [Abstract][Full Text] [Related]
13. α-Synuclein (αSyn) Preformed Fibrils Induce Endogenous αSyn Aggregation, Compromise Synaptic Activity and Enhance Synapse Loss in Cultured Excitatory Hippocampal Neurons.
Wu Q; Takano H; Riddle DM; Trojanowski JQ; Coulter DA; Lee VM
J Neurosci; 2019 Jun; 39(26):5080-5094. PubMed ID: 31036761
[TBL] [Abstract][Full Text] [Related]
14. Advances in modelling alpha-synuclein-induced Parkinson's diseases in rodents: Virus-based models versus inoculation of exogenous preformed toxic species.
Carta AR; Boi L; Pisanu A; Palmas MF; Carboni E; De Simone A
J Neurosci Methods; 2020 May; 338():108685. PubMed ID: 32173400
[TBL] [Abstract][Full Text] [Related]
15. The role of lipids in α-synuclein misfolding and neurotoxicity.
Ugalde CL; Lawson VA; Finkelstein DI; Hill AF
J Biol Chem; 2019 Jun; 294(23):9016-9028. PubMed ID: 31064841
[TBL] [Abstract][Full Text] [Related]
16. Defining the native state of α-synuclein.
Selkoe D; Dettmer U; Luth E; Kim N; Newman A; Bartels T
Neurodegener Dis; 2014; 13(2-3):114-7. PubMed ID: 24192542
[TBL] [Abstract][Full Text] [Related]
17. Human myeloperoxidase (hMPO) is expressed in neurons in the substantia nigra in Parkinson's disease and in the hMPO-α-synuclein-A53T mouse model, correlating with increased nitration and aggregation of α-synuclein and exacerbation of motor impairment.
Maki RA; Holzer M; Motamedchaboki K; Malle E; Masliah E; Marsche G; Reynolds WF
Free Radic Biol Med; 2019 Sep; 141():115-140. PubMed ID: 31175983
[TBL] [Abstract][Full Text] [Related]
18. Physiological C-terminal truncation of α-synuclein potentiates the prion-like formation of pathological inclusions.
Sorrentino ZA; Vijayaraghavan N; Gorion KM; Riffe CJ; Strang KH; Caldwell J; Giasson BI
J Biol Chem; 2018 Dec; 293(49):18914-18932. PubMed ID: 30327435
[TBL] [Abstract][Full Text] [Related]
19. Investigation of Endocytic Pathways for the Internalization of Exosome-Associated Oligomeric Alpha-Synuclein.
Delenclos M; Trendafilova T; Mahesh D; Baine AM; Moussaud S; Yan IK; Patel T; McLean PJ
Front Neurosci; 2017; 11():172. PubMed ID: 28424577
[TBL] [Abstract][Full Text] [Related]
20. Small-Molecule-Induced Soluble Oligomers of α-Synuclein with Helical Structure.
Fonseca-Ornelas L; Schmidt C; Camacho-Zarco AR; Fernandez CO; Becker S; Zweckstetter M
Chemistry; 2017 Sep; 23(53):13010-13014. PubMed ID: 28763125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
